Perceived Risk for Severe COVID-19 and Oral Antiviral Use Among Antiviral-Eligible US Adults.

Kate PenroseAvantika SrivastavaYanhan ShenMcKaylee M RobertsonSarah G KulkarniKristen E AllenThomas M PorterLaura PuzniakJohn M McLaughlinDenis Nash

Published in: Infectious diseases and therapy (2024)

Despite widespread awareness of the availability of COVID-19 oral antivirals, more than 80% of eligible US adults did not receive them. Our findings suggest that differences between perceived and actual risk for severe COVID-19 (based on current CDC guidelines) may partially explain this low uptake.

Keyphrases

coronavirus disease
sars cov
social support
depressive symptoms
physical activity
mental health
respiratory syndrome coronavirus
clinical practice
cell cycle